284 related articles for article (PubMed ID: 30791110)
1. The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B.
Ren L; Zeng M; Tang Z; Li M; Wang X; Xu Y; Weng Y; Wang X; Wang H; Guo L; Zuo B; Wang X; Wang S; Lou J; Tang Y; Mu D; Zheng N; Wu X; Han J; Carr AM; Jeggo P; Liu C
Hepatology; 2019 Jun; 69(6):2546-2561. PubMed ID: 30791110
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
3. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6.
Rivière L; Quioc-Salomon B; Fallot G; Halgand B; Féray C; Buendia MA; Neuveut C
Antiviral Res; 2019 Dec; 172():104618. PubMed ID: 31600532
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation.
Ahodantin J; Bou-Nader M; Cordier C; Mégret J; Soussan P; Desdouets C; Kremsdorf D
Oncogene; 2019 Apr; 38(14):2645-2657. PubMed ID: 30538294
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
7. HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein.
Gao W; Jia Z; Tian Y; Yang P; Sun H; Wang C; Ding Y; Zhang M; Zhang Y; Yang D; Tian Z; Zhou J; Ruan Z; Wu Y; Ni B
Hepatology; 2020 May; 71(5):1678-1695. PubMed ID: 31544250
[TBL] [Abstract][Full Text] [Related]
8. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
10. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.
Sartorius K; An P; Winkler C; Chuturgoon A; Li X; Makarova J; Kramvis A
Front Immunol; 2021; 12():661204. PubMed ID: 33995383
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of Phylogenetically Conserved Amino Acid Residues Confines HBx within Different Cell Compartments of Human Hepatocarcinoma Cells.
Prieto C; Montecinos J; Jiménez G; Riquelme C; Garrido D; Hernández S; Loyola A; Villanueva RA
Molecules; 2021 Feb; 26(5):. PubMed ID: 33652602
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
13. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
14. Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma.
Na TY; Ka NL; Rhee H; Kyeong D; Kim MH; Seong JK; Park YN; Lee MO
Oncogene; 2016 Oct; 35(41):5435-5445. PubMed ID: 27041572
[TBL] [Abstract][Full Text] [Related]
15. The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication.
Gearhart TL; Bouchard MJ
J Virol; 2010 Mar; 84(6):2675-86. PubMed ID: 20053744
[TBL] [Abstract][Full Text] [Related]
16. HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma Tumorigenesis.
Wang Q; Cheng ST; Chen J
Int J Med Sci; 2020; 17(12):1783-1794. PubMed ID: 32714081
[No Abstract] [Full Text] [Related]
17. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
18. HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma.
Zhao Z; Hu Y; Shen X; Lao Y; Zhang L; Qiu X; Hu J; Gong P; Cui H; Lu S; Zheng Y; Zhou M; Fan H
Oncol Rep; 2017 May; 37(5):2811-2818. PubMed ID: 28339081
[TBL] [Abstract][Full Text] [Related]
19. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis.
Tian Y; Yang W; Song J; Wu Y; Ni B
Mol Cell Biol; 2013 Aug; 33(15):2810-6. PubMed ID: 23716588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
